Indiva Ltd
Change company Symbol lookup
Select an option...
NDVAF Indiva Ltd
VVI Viad Corp
GTY Getty Realty Corp
SWX Southwest Gas Holdings Inc
EFR Eaton Vance Senior Floating-Rate Trust
FSRXW FinServ Acquisition II Equity Warrant Exp 17 Feb 2026 *W EXP 02/17/2026
PTRA Proterra Inc
IH Ihuman Inc
LMT Lockheed Martin Corp
GBRGU Goldenbridge Acquisition Ltd
Go

Health Care : Pharmaceuticals | Small Cap Blend
Based in Canada
Company profile

Indiva Limited (Indiva) is a Canada-based company. The Company is engaged in the business of production and sale of medical and recreational cannabis and cannabis-based products, including premium pre-rolls, flower, capsules, oils, and edible products and provides production and manufacturing services to peer entities. It is a Canadian licensed producer and distributor of cannabis products nationally, including Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Sapphire Cannabis Salt, as well as capsules, pre-rolls and premium flower under the INDIVA and Artisan Batch brands. In the adult-use market, the Company distributes its products in the provinces of Ontario, Quebec, British Columbia, Alberta, Nova Scotia, New Brunswick, Newfoundland, Manitoba and Saskatchewan, and the Yukon and Northwest Territories.

Price
Delayed
$0.22
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.24
Day's Low
0.22
Volume
(Heavy Day)

Today's volume of 55,910 shares is on pace to be much greater than NDVAF's 10-day average volume of 58,453 shares.

55,910

Bristol Myers Squibb Co. Stock Outperforms Market On Strong Trading Day

4:41 pm ET October 15, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) rallied 1.14% to $58.36 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.75% to 4,471.37 and the Dow Jones Industrial Average rising 1.09% to 35,294.76. This was the stock's third consecutive day of gains. Bristol Myers Squibb Co. closed $11.39 below its 52-week high ($69.75), which the company achieved on August 23rd.

The stock outperformed some of its competitors Friday, as Johnson & Johnson (JNJ) rose 0.74% to $161.30, Merck & Co. Inc. (MRK) remained unchanged, and Pfizer Inc. (PFE) fell 0.43% to $41.49. Trading volume (9.4 M) remained 32,852 below its 50-day average volume of 9.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 15, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

October 15, 2021 16:41 ET (20:41 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.